Portfolio company
Oncoinvent ASA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This deep-tech company develops injectable alpha radiation therapies for patients with cancers located in the peritoneal cavity.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Full-Life Technologies
This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.
Alpha-9 Theranostics
This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.
Alpha Tau Medical
This oncology company develops intratumoral alpha-emitting radiation therapy devices to treat patients with solid tumours.
Tubulis
This deep-tech company develops antibody-drug conjugates to treat patients with solid tumours.
Circle Pharma
This deep-tech company develops macrocycle-based therapies to treat cancer and other serious illnesses for patients requiring targeted medical treatments.
AdvanCell
AdvanCell develops targeted alpha therapies and isotope generators to treat cancer patients through a vertically integrated radiopharmaceutical platform.
Asgard Therapeutics
The company develops gene therapies that reprogramme cancer cells into immune cells for patients with various types of tumours.
Aktis Oncology
This biotechnology company develops alpha-emitting radiopharmaceuticals to treat patients with solid tumor cancers.